TRILLIUM THERAPEUTICS INC - COM NEW Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2014 to Q1 2022

Type / Class
Equity / COM NEW
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q1 0 $0 -$18,000 0
2021 Q4 1,049 $18,000 -$1,291,570,293 $17.16 1
2021 Q3 77,632,016 $1,363,417,099 +$133,218,058 $17.56 175
2021 Q2 84,120,192 $815,961,572 +$78,686,366 $9.70 135
2021 Q1 75,492,617 $810,596,588 -$14,666,450 $10.74 121
2020 Q4 75,954,164 $1,117,203,308 +$78,589,190 $14.71 128
2020 Q3 67,922,906 $965,254,299 +$196,533,023 $14.21 113
2020 Q2 56,278,827 $455,421,637 -$7,576,465 $8.09 83
2020 Q1 60,530,436 $244,211,456 +$185,667,444 $4.04 65
2019 Q4 8,563,793 $8,804,679 +$3,526,270 $1.03 18
2019 Q3 6,825,503 $2,098,020 +$42,662 $0.31 17
2019 Q2 6,683,504 $2,198,019 -$325,259 $0.33 15
2019 Q1 7,005,595 $4,617,042 +$583,969 $0.66 22
2018 Q4 5,788,596 $9,905,113 -$9,047,044 $1.71 22
2018 Q3 6,958,612 $40,344,367 -$310,482 $5.80 25
2018 Q2 7,011,503 $42,075,379 -$3,789,535 $6.00 28
2018 Q1 7,504,115 $54,015,466 +$1,446,046 $7.20 26
2017 Q4 7,301,096 $53,050,456 +$17,399,883 $7.25 25
2017 Q3 5,093,985 $26,226,626 -$878,582 $5.15 20
2017 Q2 5,339,239 $23,246,826 +$14,903,959 $4.40 23
2017 Q1 2,341,035 $14,423,111 -$1,714,679 $6.15 21
2016 Q4 2,645,326 $14,949,000 -$17,101,352 $5.65 29
2016 Q3 3,466,822 $51,245,000 +$5,994,500 $14.78 31
2016 Q2 3,071,948 $27,566,000 -$1,079,407 $8.98 26
2016 Q1 3,189,049 $29,496,000 -$3,218,720 $9.25 28
2015 Q4 3,510,493 $44,252,000 +$731,076 $12.61 26
2015 Q3 3,448,100 $44,811,000 +$1,231,989 $13.03 29
2015 Q2 3,206,032 $69,914,000 +$49,413,509 $21.82 33
2015 Q1 941,232 $19,033,000 +$11,333,757 $20.23 13
2014 Q4 380,248 $3,422,500 +$3,073,500 $9.00 6